The Journal of Community and Supportive OncologyDavid Henry's JCSO podcast, November 2014November 30, 2014Follicular Lymphoma
The Journal of Community and Supportive OncologySuperior vena cava syndrome as an initial presentation of low-grade follicular lymphomaNovember 17, 2014Lymphoma & Plasma Cell DisordersFollicular Lymphoma
The Journal of Community and Supportive OncologyA wonderful lifeNovember 17, 2014Patient & Survivor CareLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersLung CancerFollicular Lymphoma
Hematology TimesAspartame, sweetened drinks don’t increase risk of NHLNovember 7, 2014Lymphoma & Plasma Cell DisordersMultiple MyelomaFollicular Lymphoma
Hematology TimesMaintenance may be unnecessary in FLOctober 1, 2014Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Oncology PracticePET-CT better predicted follicular lymphoma survivalSeptember 24, 2014Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesIdelalisib approved to treat CLL, FL in EUSeptember 20, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyFollicular Lymphoma
Hematology TimesStudy supports new gold standard for FLSeptember 18, 2014Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesCHMP recommends ibrutinib for CLL, MCLJuly 27, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyFollicular Lymphoma
Hematology TimesCHMP recommends idelalisib for CLL, FLJuly 26, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyFollicular Lymphoma
Hematology TimesFDA approves idelalisib for CLL, SLL and FLJuly 24, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyFollicular Lymphoma
Oncology PracticeFDA approves idelalisib for three leukemia and lymphoma indicationsJuly 23, 2014Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationFollicular Lymphoma
Hematology TimesCombo appears safe and active in CLL, NHLJuly 23, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesSurvival differences in blood cancers across EuropeJuly 14, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaFollicular Lymphoma
Hematology TimesNovel agent shows promising activity in heavily pretreated NHLJune 11, 2014Lymphoma & Plasma Cell DisordersFollicular Lymphoma
